{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T02:40:11Z","timestamp":1682649611700},"reference-count":34,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.bbapap.2004.02.005","type":"journal-article","created":{"date-parts":[[2004,3,5]],"date-time":"2004-03-05T10:48:40Z","timestamp":1078483720000},"page":"281-284","source":"Crossref","is-referenced-by-count":0,"title":["Crystallization and preliminary X-ray diffraction analysis of an acidic phospholipase A2 complexed with p-bromophenacyl bromide and \u03b1-tocopherol inhibitors at 1.9- and 1.45-\u00c5 resolution"],"prefix":"10.1016","volume":"1699","author":[{"given":"Agnes A.S.","family":"Takeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana I.","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana","family":"Marcussi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas B.","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreimar M.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos R.M.","family":"Fontes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbapap.2004.02.005_BIB1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1388-1981(00)00105-0","article-title":"The expanding superfamily of phospholipase A2 enzymes: classification and characterization","volume":"1488","author":"Six","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbapap.2004.02.005_BIB2","series-title":"Handbook of Toxinology","first-page":"67","author":"Rosenberg","year":"1990"},{"key":"10.1016\/j.bbapap.2004.02.005_BIB3","series-title":"Venom Phospholipase A2 Enzymes: Structure, Function and Mechanism","first-page":"321","article-title":"Phospholipase A2 myotoxins from Bothrops snake venoms","author":"Guti\u00e9rrez","year":"1997"},{"key":"10.1016\/j.bbapap.2004.02.005_BIB4","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3109\/15569549809009250","article-title":"Structure, function and byophysical aspects of the myotoxins from snake venoms","volume":"17","author":"Ownby","year":"1998","journal-title":"J. Toxicol., Toxin Rev."},{"key":"10.1016\/j.bbapap.2004.02.005_BIB5","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0300-9084(00)01168-8","article-title":"What can venom phospholipase A2 tell us about the functional diversity of mammalian secreted phospholipase A2?","volume":"82","author":"Valentin","year":"2000","journal-title":"Biochimie"},{"key":"10.1016\/j.bbapap.2004.02.005_BIB6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0041-0101(89)90013-5","article-title":"A model to explain the pharmacological effects of snake venom phospholipases A2","volume":"27","author":"Kini","year":"1989","journal-title":"Toxicon"},{"key":"10.1016\/j.bbapap.2004.02.005_BIB7","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.toxicon.2003.11.004","article-title":"Chemical modifications on phospholipases A2 from snake venoms: Effects on catalytic and pharmacological properties. Review","volume":"42","author":"Soares","year":"2004","journal-title":"Toxicon"},{"key":"10.1016\/j.bbapap.2004.02.005_BIB8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev.bi.55.070186.000441","article-title":"Arachidonic acid metabolism","volume":"55","author":"Needleman","year":"1986","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbapap.2004.02.005_BIB9","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0021-9258(19)49575-6","article-title":"Tocopherol analogs suppress arachidonic acid metabolism via phospholipase inhibition","volume":"267","author":"Pentland","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.02.005_BIB10","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0891-5849(00)00425-1","article-title":"Synergistic inhibition of cyclooxygenase-2 by vitamin E and aspirin","volume":"29","author":"Abate","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbapap.2004.02.005_BIB11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0301-0082(95)00029-1","article-title":"Oxidative stress and antioxidant therapy in Parkinson's disease","volume":"48","author":"Ebadi","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbapap.2004.02.005_BIB12","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJM199704243361704","article-title":"A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study","volume":"336","author":"Sano","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbapap.2004.02.005_BIB13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0022-2836(02)00473-4","article-title":"First structural evidence of a specific inhibition of phospholipase A2 by alpha-tocopherol (vitamin E) and its implications in inflammation: Crystal structure of the complex formed between phospholipase A2 and alpha-tocopherol at 1.8 A resolution","volume":"320","author":"Chandra","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbapap.2004.02.005_BIB14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1095-6433(98)10136-8","article-title":"Geographic variations in the composition of myotoxins from Bothrops neuwiedi snake venom: biochemical characterization and biological activity","volume":"121A","author":"Rodrigues","year":"1998","journal-title":"Comp. Biochem. Physiol."},{"key":"10.1016\/j.bbapap.2004.02.005_BIB15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1006\/abbi.2000.1790","article-title":"Structural and function characterization of BnSP-7, a Lys49 myotoxic phospholipase A2 homologue from Bothrops neuwiedi venom","volume":"378","author":"Soares","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbapap.2004.02.005_BIB16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0041-0101(97)00169-4","article-title":"Structure of a snake venom phospholipase A2 modified by p-bromo-phenacyl-bromide","volume":"36","author":"Zhao","year":"1998","journal-title":"Toxicon"},{"key":"10.1016\/j.bbapap.2004.02.005_BIB17","first-page":"181","article-title":"Crystal structure of bovine pancreatic phospholipase A2 covalently inhibited by p-bromo-phenacyl-bromide","volume":"200","author":"Renetseder","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2004.02.005_BIB18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1107\/S0907444994011455","article-title":"Structure of a calcium-independent phospholipase-like myotoxic protein from Bothrops asper","volume":"51","author":"Arni","year":"1995","journal-title":"Acta Crystallogr., D Biol. Crystallogr."},{"key":"10.1016\/j.bbapap.2004.02.005_BIB19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2174\/092986650405221017153439","article-title":"Crystal structure of myotoxin-II: a myotoxic phospholipase A2 homologue from Bothrops moojeni venom","volume":"4","author":"de Azevedo","year":"1997","journal-title":"Prot. Peptide Letters"},{"key":"10.1016\/j.bbapap.2004.02.005_BIB20","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/(SICI)1097-0134(19980301)30:4<442::AID-PROT11>3.0.CO;2-I","article-title":"Crystallographic and spectroscopic characterization of a molecular hinge: conformational changes in bothropstoxin I, a dimeric Lys49-phospholipase A2 homologue","volume":"30","author":"da Silva-Giotto","year":"1998","journal-title":"Protein Struct.-Funct. Gen."},{"key":"10.1016\/j.bbapap.2004.02.005_BIB21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1021\/bi0010470","article-title":"Structural basis for low catalytic activity in Lys49-phospholipase A2 - A hypothesis: the crystal structure of piratoxin II complexed to fatty acid","volume":"40","author":"Lee","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2004.02.005_BIB22","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bbrc.2003.10.047","article-title":"Crystal Structures of BnSP-7 and BnSP-6, Two Lys49-Phospholipases A2: quaternary structure and inhibition mechanism insights","volume":"311","author":"Magro","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbapap.2004.02.005_BIB23","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/0041-0101(94)90391-3","article-title":"Purification of an acidic phospholipase A2 from Bothrops lanceolatus (fer de lance) venom: molecular and enzymatic properties","volume":"32","author":"de Ara\u00fajo","year":"1994","journal-title":"Toxicon"},{"key":"10.1016\/j.bbapap.2004.02.005_BIB24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/abbi.1995.1205","article-title":"Kinetic and pharmacological characterization of phospholipases A2 from Bothrops neuwiedii venom","volume":"318","author":"Daniele","year":"1995","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbapap.2004.02.005_BIB25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1006\/abbi.1999.1230","article-title":"A novel phospholipase A2, BJ-PLA2, from the venom of the snake Bothrops jararaca: purification, primary structure analysis, and its characterization as a platelet-aggregation-inhibiting factor","volume":"367","author":"Serrano","year":"1999","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbapap.2004.02.005_BIB26","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0041-0101(88)90244-9","article-title":"Fractionation of Bothrops jararacussu snake venom: partial chemical characterization and biological activity of bothropstoxin","volume":"26","author":"Homsi-Brandeburgo","year":"1988","journal-title":"Toxicon"},{"key":"10.1016\/j.bbapap.2004.02.005_BIB27","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1023\/A:1022563401413","article-title":"The amino acid sequence of bothropstoxin-II, an Asp-49 myotoxin from Bothrops jararacussu (jararacu\u00e7u) venom with low phospholipase A2 activity","volume":"17","author":"Pereira","year":"1998","journal-title":"J. Protein Chem."},{"key":"10.1016\/j.bbapap.2004.02.005_BIB28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0006-2952(02)01210-8","article-title":"Structural and functional characterization of an acidic platelet aggregation inhibitor and hypotensive phospholipase A2 from Bothrops jararacussu snake venom","volume":"64","author":"Andri\u00e3o-Escarso","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbapap.2004.02.005_BIB29","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2004.05.020","article-title":"Cloning and identification of a complete cDNA coding for a bactericidal and anti-tumoral acidic phospholipase A2 from Bothrops jararacussu venomous gland library","author":"Roberto","year":"2004","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.bbapap.2004.02.005_BIB30","article-title":"Cloning and expression of an acidic platelet aggregation inhibitor phospholipase A2 cDNA from Bothrops jararacussu venomous gland","author":"Roberto","year":"2003","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.bbapap.2004.02.005_BIB31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1107\/S0021889891004430","article-title":"Sparce matrix sampling: a screen method for crystallization of proteins","volume":"24","author":"Jancarik","year":"1991","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.bbapap.2004.02.005_BIB32","series-title":"Preparation and Analysis of Protein Crystals","author":"MacPherson","year":"1982"},{"key":"10.1016\/j.bbapap.2004.02.005_BIB33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbapap.2004.02.005_BIB34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1107\/S0108767393007597","article-title":"AMoRe: an automated package for molecular replacement","volume":"A50","author":"Navaza","year":"1994","journal-title":"Acta Crystallogr."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963904000329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963904000329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T02:06:19Z","timestamp":1682647579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570963904000329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":34,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S1570963904000329"],"URL":"https:\/\/doi.org\/10.1016\/j.bbapap.2004.02.005","relation":{},"ISSN":["1570-9639"],"issn-type":[{"value":"1570-9639","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}